vs
Side-by-side financial comparison of ACNB CORP (ACNB) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $47.2M, roughly 1.6× ACNB CORP). ACNB CORP runs the higher net margin — 22.9% vs 7.4%, a 15.5% gap on every dollar of revenue. On growth, ACNB CORP posted the faster year-over-year revenue change (42.2% vs 25.5%). ACNB CORP produced more free cash flow last quarter ($52.6M vs $9.7M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 22.1%).
ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
ACNB vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $76.2M |
| Net Profit | $10.8M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | 27.9% | 11.0% |
| Net Margin | 22.9% | 7.4% |
| Revenue YoY | 42.2% | 25.5% |
| Net Profit YoY | 63.8% | 30.7% |
| EPS (diluted) | $1.10 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.2M | $76.2M | ||
| Q3 25 | $50.9M | $71.9M | ||
| Q2 25 | $50.3M | $63.1M | ||
| Q1 25 | $43.5M | $59.1M | ||
| Q4 24 | $33.2M | $60.7M | ||
| Q3 24 | $34.1M | $58.0M | ||
| Q2 24 | $33.3M | $55.0M | ||
| Q1 24 | $31.6M | $50.6M |
| Q4 25 | $10.8M | $5.6M | ||
| Q3 25 | $14.9M | $3.5M | ||
| Q2 25 | $11.6M | $3.2M | ||
| Q1 25 | $-272.0K | $2.6M | ||
| Q4 24 | $6.6M | $4.3M | ||
| Q3 24 | $7.2M | $3.9M | ||
| Q2 24 | $11.3M | $1.5M | ||
| Q1 24 | $6.8M | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | 27.9% | 11.0% | ||
| Q3 25 | 37.2% | 7.8% | ||
| Q2 25 | 29.7% | 8.1% | ||
| Q1 25 | -1.3% | 6.5% | ||
| Q4 24 | 24.8% | 10.6% | ||
| Q3 24 | 27.6% | 9.7% | ||
| Q2 24 | 42.8% | 6.6% | ||
| Q1 24 | 26.9% | 4.4% |
| Q4 25 | 22.9% | 7.4% | ||
| Q3 25 | 29.2% | 4.9% | ||
| Q2 25 | 23.2% | 5.0% | ||
| Q1 25 | -0.6% | 4.4% | ||
| Q4 24 | 19.9% | 7.1% | ||
| Q3 24 | 21.1% | 6.7% | ||
| Q2 24 | 33.9% | 2.7% | ||
| Q1 24 | 21.4% | 3.2% |
| Q4 25 | $1.10 | $0.14 | ||
| Q3 25 | $1.42 | $0.09 | ||
| Q2 25 | $1.11 | $0.08 | ||
| Q1 25 | $-0.03 | $0.06 | ||
| Q4 24 | $0.77 | $0.10 | ||
| Q3 24 | $0.84 | $0.10 | ||
| Q2 24 | $1.32 | $0.04 | ||
| Q1 24 | $0.80 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $13.5M |
| Total DebtLower is stronger | $255.4M | — |
| Stockholders' EquityBook value | $420.0M | $141.5M |
| Total Assets | $3.2B | $199.2M |
| Debt / EquityLower = less leverage | 0.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | $13.5M | ||
| Q3 25 | $102.1M | $11.1M | ||
| Q2 25 | $103.1M | $20.0M | ||
| Q1 25 | $123.6M | $10.2M | ||
| Q4 24 | $47.3M | $17.5M | ||
| Q3 24 | $58.1M | $11.3M | ||
| Q2 24 | $86.3M | $8.8M | ||
| Q1 24 | $53.1M | $7.3M |
| Q4 25 | $255.4M | — | ||
| Q3 25 | $255.4M | — | ||
| Q2 25 | $255.4M | — | ||
| Q1 25 | $255.3M | — | ||
| Q4 24 | $255.3M | — | ||
| Q3 24 | $255.3M | — | ||
| Q2 24 | $255.3M | — | ||
| Q1 24 | $255.3M | — |
| Q4 25 | $420.0M | $141.5M | ||
| Q3 25 | $408.6M | $133.6M | ||
| Q2 25 | $395.2M | $139.7M | ||
| Q1 25 | $386.9M | $134.8M | ||
| Q4 24 | $303.3M | $131.4M | ||
| Q3 24 | $306.8M | $125.0M | ||
| Q2 24 | $289.3M | $119.4M | ||
| Q1 24 | $279.9M | $116.3M |
| Q4 25 | $3.2B | $199.2M | ||
| Q3 25 | $3.3B | $202.4M | ||
| Q2 25 | $3.3B | $184.6M | ||
| Q1 25 | $3.3B | $178.1M | ||
| Q4 24 | $2.4B | $177.1M | ||
| Q3 24 | $2.4B | $169.5M | ||
| Q2 24 | $2.5B | $163.9M | ||
| Q1 24 | $2.4B | $154.9M |
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 0.65× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.84× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.91× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.6M | $18.4M |
| Free Cash FlowOCF − Capex | $52.6M | $9.7M |
| FCF MarginFCF / Revenue | 111.4% | 12.7% |
| Capex IntensityCapex / Revenue | 2.3% | 11.5% |
| Cash ConversionOCF / Net Profit | 4.96× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.6M | $18.4M | ||
| Q3 25 | $23.2M | $18.4M | ||
| Q2 25 | $17.8M | $12.3M | ||
| Q1 25 | $-71.0K | $2.9M | ||
| Q4 24 | $39.8M | $15.0M | ||
| Q3 24 | $13.6M | $12.7M | ||
| Q2 24 | $9.7M | $10.2M | ||
| Q1 24 | $10.8M | $1.2M |
| Q4 25 | $52.6M | $9.7M | ||
| Q3 25 | $22.8M | $10.7M | ||
| Q2 25 | $17.6M | $4.1M | ||
| Q1 25 | $-730.0K | $-12.6M | ||
| Q4 24 | $38.8M | $3.2M | ||
| Q3 24 | $13.3M | $1.7M | ||
| Q2 24 | $9.4M | $1.2M | ||
| Q1 24 | $10.7M | $-4.8M |
| Q4 25 | 111.4% | 12.7% | ||
| Q3 25 | 44.7% | 14.9% | ||
| Q2 25 | 35.0% | 6.5% | ||
| Q1 25 | -1.7% | -21.4% | ||
| Q4 24 | 117.0% | 5.2% | ||
| Q3 24 | 39.1% | 3.0% | ||
| Q2 24 | 28.3% | 2.3% | ||
| Q1 24 | 33.9% | -9.5% |
| Q4 25 | 2.3% | 11.5% | ||
| Q3 25 | 0.8% | 10.6% | ||
| Q2 25 | 0.4% | 12.9% | ||
| Q1 25 | 1.5% | 26.2% | ||
| Q4 24 | 2.9% | 19.5% | ||
| Q3 24 | 0.7% | 19.0% | ||
| Q2 24 | 0.9% | 16.3% | ||
| Q1 24 | 0.2% | 11.9% |
| Q4 25 | 4.96× | 3.27× | ||
| Q3 25 | 1.56× | 5.23× | ||
| Q2 25 | 1.52× | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | 6.03× | 3.47× | ||
| Q3 24 | 1.88× | 3.29× | ||
| Q2 24 | 0.86× | 6.94× | ||
| Q1 24 | 1.60× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
